Novozymes Biopharma And Upperton Limited Granted European Patent For Oncology Technology (Medical News Today)
Novozymes Biopharma And Upperton Limited Granted European Patent For Oncology Technology (Medical News Today)
Novozymes Biopharma and Upperton Limited today announce that the European Patent Office has confirmed the official Decision to Grant a European patent for their targeted drug delivery joint patent application (European patent No 1605979).